Literature DB >> 16870961

Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study.

Marvin S Swartz1, H Ryan Wagner, Jeffrey W Swanson, T Scott Stroup, Joseph P McEvoy, Mark McGee, Del D Miller, Fred Reimherr, Ahsan Khan, José M Cañive, Jeffrey A Lieberman.   

Abstract

OBJECTIVE: This study examined the relationship between substance use and psychosocial functioning in schizophrenia.
METHODS: Participants were enrolled in the Clinical Antipsychotic Trials of Intervention Effectiveness. This study used baseline assessments and examined psychosocial functioning assessed by the Quality of Life Scale. Participants were classified as being abstinent, using substances, or having a substance use disorder.
RESULTS: Of the 1,460 participants, 23 percent used substances and 37 percent had a substance use disorder. Of the 544 with a substance use disorder, 87 percent used alcohol, 44 percent used marijuana, and 36 percent used cocaine. Compared with participants who used substances, those with a substance use disorder had higher rates of polysubstance use. Compared with those who were abstinent, those who used substances had higher overall psychosocial functioning, and those with a substance use disorder had similar overall functioning but lower scores on the common objects and activities subscales. Among participants with a substance use disorder, those who used cocaine had lower overall functioning.
CONCLUSIONS: Compared with abstinence, substance use and substance use disorder, unless they involved cocaine use, were generally associated with higher or equivalent overall psychosocial functioning. Patterns of substance use were similar to those in the community, suggesting that treatment of substance use disorders in schizophrenia should focus on reconnecting substance users to nonusing peer groups.

Entities:  

Mesh:

Year:  2006        PMID: 16870961     DOI: 10.1176/ps.2006.57.8.1110

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  20 in total

1.  Prevalence of Substance Use in Patients Diagnosed with Schizophrenia.

Authors:  Yasemin Tekin Uludağ; Gülcan Güleç
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

2.  Accuracy of self-report, biological tests, collateral reports and clinician ratings in identifying substance use disorders among adults with schizophrenia.

Authors:  Sarah L Desmarais; Richard A Van Dorn; Brian G Sellers; M Scott Young; Marvin S Swartz
Journal:  Psychol Addict Behav       Date:  2012-12-31

3.  Functional impairment among people with severe and enduring mental disorder in rural Ethiopia: a cross-sectional study.

Authors:  Kassahun Habtamu; Atalay Alem; Girmay Medhin; Abebaw Fekadu; Charlotte Hanlon
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-06-14       Impact factor: 4.328

4.  Patterns and Predictors of Changes in Substance Use in Individuals with Schizophrenia and Affective Disorders.

Authors:  Melanie E Bennett; Clayton H Brown; Jason Peer; Lan Li; Alan S Bellack
Journal:  J Dual Diagn       Date:  2012-02-13

5.  Test-retest reliability of self-report measures in a dually diagnosed sample.

Authors:  Jon M Houck; Alyssa A Forcehimes; Elisa T Gutierrez; Michael P Bogenschutz
Journal:  Subst Use Misuse       Date:  2012-10-25       Impact factor: 2.164

6.  Measuring principal substance of abuse in comorbid patients for clinical research.

Authors:  Margaret L Griffin; Monika E Kolodziej; Roger D Weiss
Journal:  Addict Behav       Date:  2009-03-06       Impact factor: 3.913

7.  Experiences of victimisation and depression are associated with community functioning among men with schizophrenia.

Authors:  Sheilagh Hodgins; Tania Lincoln; Tim Mak
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-22       Impact factor: 4.328

8.  A candidate gene study of Tardive dyskinesia in the CATIE schizophrenia trial.

Authors:  Huei-Ting Tsai; Stanley N Caroff; Del D Miller; Joseph McEvoy; Jeffrey A Lieberman; Kari E North; T Scott Stroup; Patrick F Sullivan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

9.  Neurocognitive characteristics of individuals with schizophrenia and cocaine dependence: comparison of currently dependent and remitted groups.

Authors:  Jason Peer; Melanie E Bennett; Alan S Bellack
Journal:  J Nerv Ment Dis       Date:  2009-08       Impact factor: 2.254

10.  Assessing illicit drug use among adults with schizophrenia.

Authors:  Richard A Van Dorn; Sarah L Desmarais; M Scott Young; Brian G Sellers; Marvin S Swartz
Journal:  Psychiatry Res       Date:  2012-07-15       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.